A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
Launched by ZHE MENG · Feb 7, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new approach to help patients recover faster after a specific type of surgery called laparoscopic adrenalectomy, which is used to remove tumors from the adrenal glands. The study focuses on whether patients can have the surgery without a drainage tube, which is often used to help remove excess fluid. Researchers want to find out if going "tubeless" is safe and if it helps patients feel better more quickly, especially in terms of pain and getting back on their feet after the procedure.
To participate in this trial, you need to be between 18 and 70 years old and meet certain medical guidelines for surgery. You’ll be randomly assigned to one of two groups: one group will have the surgery without a drainage tube, and the other will have the standard approach with a tube. Throughout the study, your recovery will be monitored, including how much pain you experience and how quickly you can get out of bed and return to normal activities. If you have serious health issues or are pregnant, you may not be eligible for this trial. This study is currently looking for participants, so it could be a great opportunity to contribute to important medical research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications
- • 2. The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.
- Exclusion Criteria:
- • 1. Patients with complications that seriously affect treatment or quality of life
- • 2. The patient has any physical condition that the researcher believes will affect the clinical status
- • 3. Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year
- • 4. Pregnant or lactating patients
About Zhe Meng
Zhe Meng is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a strong focus on developing cutting-edge treatments across various therapeutic areas, Zhe Meng collaborates with healthcare professionals, regulatory agencies, and research institutions to ensure the highest standards of clinical trial design and execution. Committed to ethical practices and patient safety, the organization leverages its expertise to facilitate the efficient progression of clinical trials, ultimately contributing to the enhancement of global health and the delivery of transformative medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
meng zhe
Principal Investigator
Wuhan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported